Literature DB >> 31555858

Enhanced metastatic growth after local tumor resection in the presence of synchronous metastasis in a mouse allograft model of neuroblastoma.

Maho Inoue1,2, Yoshiki Tsuchiya3, Nobuya Koike3, Yasuhiro Umemura3, Hitoshi Inokawa3, Yuichi Togashi4, Junnosuke Maniwa4, Mayumi Higashi4, Shigehisa Fumino4, Tatsuro Tajiri4, Kazuhiro Yagita3.   

Abstract

PURPOSE: We investigated how local tumor resection affects metastatic lesions in neuroblastoma.
METHODS: MYCN Tg tumor-derived cells were injected subcutaneously into 129+Ter/SvJcl wild-type mice. First, the frequency of metastasis-bearing mice was investigated immunohistochemically (metastatic ratio) at endpoint or post-injection day (PID) 90. Second, the threshold volume of local tumor in mice bearing microscopic lymph node metastasis (mLNM) was investigated at PID 30. Finally, local tumors were resected after exceeding the threshold. Mice were divided into local tumor resection (Resection) and observation (Observation) groups, and the metastatic ratio and volume of LNM were compared between the groups at endpoint or PID 74.
RESULTS: The metastatic ratio without local resection was 88% at PID 78-90. The threshold local tumor volume in the mice with mLNM was 745 mm3 at PID 30, so local tumors were resected after exceeding 700 mm3. The metastatic ratio and LNM volume were significantly greater in the Resection group (n = 16) than in the Observation group (n = 16) (94% vs. 38%, p < 0.001; 2092 ± 2310 vs. 275 ± 218 mm3, p < 0.01; respectively) at PID 50-74.
CONCLUSION: Local tumor resection might augment the growth of synchronous microscopic metastases. Our results provide insights into the appropriate timing of local resection for high-risk neuroblastoma.

Entities:  

Keywords:  Concomitant tumor resistance; Local tumor resection; MYCN transgenic mouse; Metastasis; Neuroblastoma

Mesh:

Year:  2019        PMID: 31555858     DOI: 10.1007/s00383-019-04568-0

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  27 in total

1.  Targeted expression of MYCN causes neuroblastoma in transgenic mice.

Authors:  W A Weiss; K Aldape; G Mohapatra; B G Feuerstein; J M Bishop
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

Review 2.  Concomitant tumor resistance.

Authors:  Paula Chiarella; Juan Bruzzo; Roberto P Meiss; Raúl A Ruggiero
Journal:  Cancer Lett       Date:  2012-05-22       Impact factor: 8.679

3.  Management and outcome of stage 3 neuroblastoma.

Authors:  Shakeel Modak; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Nai-Kong V Cheung
Journal:  Eur J Cancer       Date:  2008-11-06       Impact factor: 9.162

4.  Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.

Authors:  Tal Teitz; Madoka Inoue; Marcus B Valentine; Kejin Zhu; Jerold E Rehg; Wei Zhao; David Finkelstein; Yong-Dong Wang; Melissa D Johnson; Christopher Calabrese; Marcelo Rubinstein; Razqallah Hakem; William A Weiss; Jill M Lahti
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

5.  Concomitant tumour resistance in patients with osteosarcoma. A clue to a new therapeutic strategy.

Authors:  M Kaya; T Wada; S Nagoya; S Kawaguchi; K Isu; T Yamashita
Journal:  J Bone Joint Surg Br       Date:  2004-01

6.  Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.

Authors:  Susan G Kreissman; Robert C Seeger; Katherine K Matthay; Wendy B London; Richard Sposto; Stephan A Grupp; Daphne A Haas-Kogan; Michael P Laquaglia; Alice L Yu; Lisa Diller; Allen Buxton; Julie R Park; Susan L Cohn; John M Maris; C Patrick Reynolds; Judith G Villablanca
Journal:  Lancet Oncol       Date:  2013-07-25       Impact factor: 41.316

7.  Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study.

Authors:  E Stanton Adkins; Robert Sawin; Robert B Gerbing; Wendy B London; Katherine K Matthay; Gerald M Haase
Journal:  J Pediatr Surg       Date:  2004-06       Impact factor: 2.545

Review 8.  Treatment of metastatic breast cancer: looking towards the future.

Authors:  Surabhi Amar; Vivek Roy; Edith A Perez
Journal:  Breast Cancer Res Treat       Date:  2008-05-09       Impact factor: 4.872

9.  The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG).

Authors:  Jorine 't Lam-Boer; Linda Mol; Cornelis Verhoef; Anton F J de Haan; Mette Yilmaz; Cornelis J A Punt; Johannes H W de Wilt; Miriam Koopman
Journal:  BMC Cancer       Date:  2014-10-02       Impact factor: 4.430

10.  A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model.

Authors:  Dongliang Cao; Satoshi Kishida; Peng Huang; Ping Mu; Shoma Tsubota; Masaaki Mizuno; Kenji Kadomatsu
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.